1,053 results on '"Bristol-Myers Squibb Co. -- Forecasts and trends"'
Search Results
2. Brain Tumor Therapeutics Global Research Business Report 2024-2030 Featuring Profiles of Market Leaders Including AstraZeneca, Bristol-Myers Squibb, DelMar Pharmaceuticals
3. CTLA-4 Inhibitors Market to Advance at Moderate CAGR During the Study Period (2020-2034) | DelveInsight
4. Alpha Thalassemia Market Revenue to Expand Significantly by 2034, States DelveInsight Report | Agios Pharma, Novo Nordisk, Bristol-Myers Squibb, Genmedicn Biopharma
5. Her2+ Gastric Cancer Market Report 2032: Epidemiology Insights, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Roche, Elevar Therapeutic, Bristol-Myers Squibb, Merck, Daiichi Sa
6. Progressive Pulmonary Fibrosis Market Size in the 7MM was USD 1,300 Million in 2023, estimated DelveInsight
7. Multiple Myeloma Market on Track for Major Expansion by 2034, According to DelveInsight | Janssen Pharma, Regeneron Pharma, Johnson & Johnson Innovative Medicine, Bristol Myers Squibb, Regeneron
8. United States Leads Global Pancreatic Cancer Market with 50% Share, Surpassing EU4, UK, and Japan, Reports DelveInsight | AstraZeneca, Merck Sharp & Dohme LLC, Bayer, Roche, Celgene, BMS
9. Psoriasis Market is expected to rise at a significant CAGR, DelveInsight | Hangzhou Highlightll Pharmaceutical Co., Ltd, Biohaven Pharmaceuticals, Inc., SFA Therapeutics, Bristol-Myers Squibb
10. Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight
11. CAR T-Cell Therapy For Acute Lymphoblastic Leukemia Market on Track for Major Expansion by 2034, According to DelveInsight | Eli Lilly and Company, Gilead Sciences, Novartis, Autolus Therapeutics
12. Cell and Gene Therapy Market to Grow by USD 6.56 Billion (2024-2028), Driven by Rising Prevalence of Chronic Diseases, AI-Powered Report Explores Market Evolution - Technavio
13. Acute Ischemic Stroke Market on Track for Major Expansion by 2034, According to DelveInsight | Abbvie, Acticor Biotech, Athersys, Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics
14. Rare Hematology Market to Grow by USD 4.58 Billion (2024-2028) as Strategic Portfolio Enhancements Drive Revenue; AI's Impact on Market Trends Report - Technavio
15. Rare Hematology Market to Grow by USD 4.58 Billion (2024-2028) as Strategic Portfolio Enhancements Drive Revenue; AI's Impact on Market Trends Report - Technavio
16. Anti-CD38 mAb Market to Accelerate Substantially During the Study Period (2020-2034) Owing to a Strong Uptake of DARZALEX in Multiple Myeloma and Expected Entry of anti-CD38 mAbs in Autoimmune Diseases | DelveInsight
17. Anti-CD38 mAb Market to Accelerate Substantially During the Study Period (2020-2034) Owing to a Strong Uptake of DARZALEX in Multiple Myeloma and Expected Entry of anti-CD38 mAbs in Autoimmune Diseases | DelveInsight
18. Adrenal crisis Market on Track for Major Expansion by 2034, According to DelveInsight | Takeda Pharma, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, Antares Pharma
19. Postpartum Depression Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | SAGE Therapeutics, GH Research, Bristol-Myers Squibb
20. Hypertrophic Cardiomyopathy Treatment Market Size in the 7MM was ~USD 646 Million in 2023, estimated DelveInsight
21. Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing
22. The immunology market is projected to grow by USD 65.8 Billion from 2024-2028, with AI reshaping the landscape and increasing organ transplants driving revenue - Technavio
23. Castrate-resistant Prostate Cancer Market to Show Remarkable Growth Trends from 2023 to 2032, Asserts DelveInsight | Pfizer, Astellas Pharma, Bristol-Myers Squibb, Laekna Therapeutics, Novartis
24. United States Dominates Global Pancreatic Cancer Market with 50% Share, Outpacing EU4, UK, and Japan, DelveInsight | AstraZeneca, Merck Sharp & Dohme LLC, Bayer, Roche, Celgene, Bristol Myers Squibb
25. Psoriasis Market is anticipated to rise at a notable CAGR, estimates DelveInsight | Hangzhou Highlightll Pharmaceutical Co., Ltd, Biohaven Pharmaceuticals, Inc., SFA Therapeutics, Bristol-Myers Squibb
26. Global Cancer Monoclonal Antibodies Market to Cross ~USD 157 Billion Mark by 2030 | DelveInsight
27. Global Chemotherapy Drugs Market to Grow Substantially at a CAGR of ~9% by 2030 | DelveInsight
28. BCMA-Targeted Therapies Market to Witness Upsurge in Growth During the Study Period (2020-2034) | DelveInsight
29. Celiac Diseases Drugs Market size is set to grow by USD 1.10 billion from 2024-2028, Higher consumption of gluten-containing food boost the market
30. Celiac Diseases Drugs Market size is set to grow by USD 1.10 billion from 2024-2028, Higher consumption of gluten-containing food boost the market, Technavio
31. Sarcoma Therapeutics Market size is set to grow by USD 1.11 billion from 2024-2028, Patient assistance programs boost the market, Technavio
32. Stock Market Outlook for Friday Today
33. Head and Neck Cancer Treatment Market size is set to grow by USD 7.12 billion from 2024-2028, Increasing incidence of head and neck cancers boost the market, Technavio
34. Car T-Cell Therapy Market size is set to grow by USD 3.02 billion from 2024-2028, Growing awareness regarding car T-cell therapy to boost the market growth, Technavio
35. Technavio predicts increase in global peptide therapeutics market size
36. Technavio predicts increase in global peptide therapeutics market size
37. Technavio predicts global autism spectrum disorder therapeutics market to increase in size
38. Technavio predicts global autism spectrum disorder therapeutics market to increase in size
39. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio
40. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio
41. Global Autologous Stem Cell & Non-stem Cell Therapies Market Report 2024-2029, with Comparative Analysis of Cupistem Efficacy in Treatment of Crohn's Perianal Fistulas
42. AstraZeneca: Price Upside Is Over (Rating Downgrade)
43. Checkpoint Inhibitor Refractory Cancer Market Size in the 7MM is expected to grow by 2032, estimates DelveInsight
44. NSCLC Market Size in the 7MM is expected to Grow by 2032, estimates DelveInsight
45. Ischemic Stroke Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight
46. Protein Therapeutics Market size is set to grow by USD 172.8 billion from 2024-2028, Increased demand for mAbs boost the market, Technavio
47. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market size is set to grow by USD 11.66 billion from 2024-2028, High target affinity and specificity of VEGF inhibitors to boost the market growth, Technavio
48. PD-1 and PD-L1 Inhibitors Market is expected to sour at a decent CAGR by 2020-2034, eatimates DelveInsight | Isunakinra, Dato-DXd, ONC-392, ZYNYZ (retifanlimab), Spartalizumab (PDR001), more
49. Global Diabetes Drug Analysis Report 2024: A $107.02 Billion Market by 2032 Driven by Novo Nordisk, AstraZeneca, Biocon, Sanofi, Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, Novartis
50. Multiple Sclerosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Novartis AG, Sanofi, F. Hoffmann-La Roche, Celgene Crp., Johnson & Johnson
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.